AI assistant
Xlife Sciences AG Director's Dealing 2022
1041_dirs_2022-01-21_a3d01406-da2b-442f-852f-aeabab409b5b.html
Director's Dealing
Open in viewerOpens in your device viewer
News Details
Directors’ Dealings | 21 January 2022 17:27
DGAP-DD: Xlife Sciences AG english
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
21.01.2022 / 17:26
The issuer is solely responsible for the content of this announcement.
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name
| Title: | |
| First name: | Oliver R. |
| Last name(s): | Baumann |
2. Reason for the notification
a) Position / status
| Position: | Member of the managing body |
b) Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
Xlife Sciences AG
b) LEI
984500AH590BE88BB517
4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument, identification code
| Type: | Share |
| ISIN: | CH0461929603 |
b) Nature of the transaction
Acquisition
c) Price(s) and volume(s)
| Price(s) | Volume(s) |
| 43 EUR | 21500 EUR |
d) Aggregated information
| Price | Aggregated volume |
| 43.0000 EUR | 21500.0000 EUR |
e) Date of the transaction
2022-01-21; UTC+1
f) Place of the transaction
| Name: | Frankfurt Stock Exchange |
| MIC: | XETR |
21.01.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Xlife Sciences AG |
| Talacker 35 | |
| 8001 Zürich | |
| Switzerland | |
| Internet: | www.xlifesciences.ch |
| End of News | DGAP News Service |